Congressional Research Service Reports - 40 Matching Results

Search Results

Results: 1 - 24 next
open access

Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Description: This report examines these proposals as well as the “Medicare Rx Drug Benefit and Discount Act of 2003,” which was introduced by Representative Charles Rangel, the ranking member of the House Ways and Means Committee. Specifically, this report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs.
Date: June 17, 2003
Creator: Peterson, Chris L.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Description: This report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs. In addition, this report gives examples of how annual cost-sharing would differ for beneficiaries with various levels of total prescription drug spending in 2006 under the plans.
Date: June 26, 2003
Creator: Peterson, Chris L.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Medicare Prescription Drug and Reform Legislation

Description: This report describes the major features of S. 1, as ordered reported, and the measure to be considered by the House Ways and Means Committee, H.R. 2473, as ordered reported.
Date: June 19, 2003
Creator: O'Sullivan, Jennifer; Chaikind, Hinda Ripps; Tilson, Sibyl L.; Boulanger, Jennifer & Morgan, Paulette C.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Description: Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. This report explores the issue of whether or not the substantial federal investment in health-related research and development (R&D) entitles the public to commensurate consideration in prices charged for any resulting drugs. It is intended to provide the reader with an under… more
Date: June 19, 2000
Creator: Schacht, Wendy H.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Date: June 11, 2003
Creator: Redhead, C. Stephen
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: June 23, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Description: This report describes the Proposed Legislative Changes Affecting Pharmaceutical Patents on Hatch-Waxman Act. The Hatch-Waxman Act provides the FDA with certain authorities to offer periods of marketing for a pharmaceutical independent of the rights conferred by patents.
Date: June 30, 2003
Creator: Schacht, Wendy H. & Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

AIDS in Africa

Description: Sub-Saharan Africa has been far more severely affected by AIDS than any other part of the world. The United Nations reports that 25.3 million adults and children are infected with the HIV virus in the region, which has about 10% of the world's population but more than 70% of the worldwide total of infected people. This report discusses this issue in detail, including the cause of the African AIDS epidemic, the social and economic consequences, response and treatment, and U.S. policy.
Date: June 11, 2002
Creator: Copson, Raymond W.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Background and Legal Issues Related to Stem Cell Research

Description: In August 2001, President Bush announced that federal funds, with certain restrictions, may be used to conduct research on human embryonic stem cells. Federal research is limited to “the more than 60” existing stem cell lines that were derived (1) with the informed consent of the donors; (2) from excess embryos created solely for reproductive purposes; and (3) without any financial inducements to the donors. No federal funds may be used for the derivation or use of stem cell lines derived from … more
Date: June 12, 2002
Creator: Duffy, Diane T
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

AIDS in Africa

Description: Sub-Saharan Africa has been far more severely affected by AIDS than any other part of the world. The United Nations reports that 24.5 million adults and children are infected with the HIV virus in the region, which has about 10% of the world's population but more than 64% of the worldwide total of infected people. This report discusses this issue in detail, including the cause of the African AIDS epidemic, the social and economic consequences, response and treatment, and U.S. policy.
Date: June 29, 2005
Creator: Copson, Raymond W.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Medicaid and SCHIP: The President's FY2006 Budget Proposals

Description: This report describes the proposal and provides an estimate of the cost or savings based on publicly available information. The report provides a brief background for the proposal and provides a listing of current Congressional Research Service (CRS) reports related to the proposal.
Date: June 9, 2005
Creator: Grady, April; Hearne, Jean P.; Herz, Elicia J.; Scott, Christine; Stone-Axelrad, Julie & Tritz, Karen
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
Back to Top of Screen